Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $13.3500 (-4.98%) ($13.1700 - $14.3000) on Thu. Aug. 15, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.29% (three month average) | RSI | 39 | Latest Price | $13.3500(-4.98%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.2% a day on average for past five trading days. | Weekly Trend | ATRA declines -2.1% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -1.645% in a week (0% probabilities). VIXM(-35%) VXX(-34%) TLT(-12%) UNG(-7%) IFRA(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.645% (StdDev 3.29%) | Hourly BBV | 0 () | Intraday Trend | -4.8% | | | |
|
Resistance Level | $13.8 | 5 Day Moving Average | $13.66(-2.27%) | 10 Day Moving Average | $13.08(2.06%) | 20 Day Moving Average | $13.8(-3.26%) | To recent high | -46.3% | To recent low | 11% | Market Cap | $992m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |